261 filings
Page 4 of 14
4
Gannon Steven
14 Jun 23
Fusion Pharmaceuticals / STEVEN GANNON ownership change
5:07pm
4
Duncan Barbara Gayle
14 Jun 23
Fusion Pharmaceuticals / Barbara Gayle Duncan ownership change
5:06pm
4
FUSN
Fusion Pharmaceuticals Inc
14 Jun 23
Fusion Pharmaceuticals / PABLO J CAGNONI ownership change
5:05pm
4
FUSN
Fusion Pharmaceuticals Inc
14 Jun 23
Fusion Pharmaceuticals / Donald A Bergstrom ownership change
5:04pm
SC 13G/A
FUSN
Fusion Pharmaceuticals Inc
9 Jun 23
Fusion Pharmaceuticals / FEDERATED HERMES ownership change
8:19am
SC 13D/A
Orbimed Advisors LLC
16 May 23
Fusion Pharmaceuticals / ORBIMED ADVISORS ownership change
4:28pm
10-Q
2023 Q1
FUSN
Fusion Pharmaceuticals Inc
Quarterly report
11 May 23
8:01am
8-K
FUSN
Fusion Pharmaceuticals Inc
11 May 23
Fusion Pharmaceuticals Announces First Quarter 2023 Financial Results and Clinical Program Updates
7:46am
ARS
2022 FY
FUSN
Fusion Pharmaceuticals Inc
27 Apr 23
Annual report to shareholders
4:43pm
DEFA14A
FUSN
Fusion Pharmaceuticals Inc
27 Apr 23
Additional proxy soliciting materials
4:34pm
DEF 14A
FUSN
Fusion Pharmaceuticals Inc
Definitive proxy
27 Apr 23
4:31pm
EFFECT
FUSN
Fusion Pharmaceuticals Inc
24 Mar 23
Notice of effectiveness
12:15am
CORRESP
FUSN
Fusion Pharmaceuticals Inc
21 Mar 23
Correspondence with SEC
12:00am
UPLOAD
FUSN
Fusion Pharmaceuticals Inc
21 Mar 23
Letter from SEC
12:00am
S-3
FUSN
Fusion Pharmaceuticals Inc
Shelf registration
16 Mar 23
4:02pm
S-8
FUSN
Fusion Pharmaceuticals Inc
16 Mar 23
Registration of securities for employees
8:16am
10-K
2022 FY
FUSN
Fusion Pharmaceuticals Inc
Annual report
16 Mar 23
8:01am
8-K
FUSN
Fusion Pharmaceuticals Inc
16 Mar 23
Fusion Pharmaceuticals Announces Fourth Quarter 2022 Financial Results and Clinical Program Updates
7:45am
8-K
FUSN
Fusion Pharmaceuticals Inc
10 Mar 23
Regulation FD Disclosure
3:15pm
SC 13D/A
HealthCap VII, L.P.
6 Mar 23
Fusion Pharmaceuticals / HealthCap VII ownership change
4:06pm